These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25774345)

  • 41. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
    Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
    Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs and myocardial infarction.
    D'Alessandra Y; Pompilio G; Capogrossi MC
    Curr Opin Cardiol; 2012 May; 27(3):228-35. PubMed ID: 22476028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating MicroRNAs as Novel Biomarkers in Risk Assessment and Prognosis of Coronary Artery Disease.
    Vavassori C; Cipriani E; Colombo GI
    Eur Cardiol; 2022 Feb; 17():e06. PubMed ID: 35321524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
    Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris.
    Li HY; Zhao X; Liu YZ; Meng Z; Wang D; Yang F; Shi QW
    Cell Physiol Biochem; 2016; 39(3):837-46. PubMed ID: 27497911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarction.
    Ornek E; Murat S; Duran M; Turfan M; Kurtul A; Demircelik MB; Vatankulu MA; Ocek H; Akdemir R
    Clin Invest Med; 2011 Feb; 34(1):E14-20. PubMed ID: 21291631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
    Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miRNA in Prostate Cancer: New Prospects for Old Challenges.
    Mekhail SM; Yousef PG; Jackinsky SW; Pasic M; Yousef GM
    EJIFCC; 2014 Apr; 25(1):79-98. PubMed ID: 27683458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p Are Novel Biomarkers for Diagnosis of Acute Myocardial Infarction.
    Xue S; Liu D; Zhu W; Su Z; Zhang L; Zhou C; Li P
    Front Physiol; 2019; 10():123. PubMed ID: 30833907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting microRNAs for cardiovascular therapeutics in coronary artery disease.
    Hinkel R; Ng JK; Kupatt C
    Curr Opin Cardiol; 2014 Nov; 29(6):586-94. PubMed ID: 25159281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise responsive micro ribonucleic acids identify patients with coronary artery disease.
    Mayr B; Müller EE; Schäfer C; Droese S; Breitenbach-Koller H; Schönfelder M; Niebauer J
    Eur J Prev Cardiol; 2019 Mar; 26(4):348-355. PubMed ID: 30373378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease.
    Peters LJF; Biessen EAL; Hohl M; Weber C; van der Vorst EPC; Santovito D
    Front Physiol; 2020; 11():793. PubMed ID: 32733281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Roles of microRNAs in the Cardiovascular System.
    Nappi F; Avtaar Singh SS; Jitendra V; Alzamil A; Schoell T
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HDL and microRNA therapeutics in cardiovascular disease.
    Michell DL; Vickers KC
    Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.
    Li M; Zhang J
    Biomed Res Int; 2015; 2015():730535. PubMed ID: 26180810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review.
    Agrawal S; Tapmeier T; Rahmioglu N; Kirtley S; Zondervan K; Becker C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating microRNAs as emerging cardiac biomarkers responsive to acute exercise.
    de Gonzalo-Calvo D; Dávalos A; Fernández-Sanjurjo M; Amado-Rodríguez L; Díaz-Coto S; Tomás-Zapico C; Montero A; García-González Á; Llorente-Cortés V; Heras ME; Boraita Pérez A; Díaz-Martínez ÁE; Úbeda N; Iglesias-Gutiérrez E
    Int J Cardiol; 2018 Aug; 264():130-136. PubMed ID: 29776561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.
    Gupta SK; Foinquinos A; Thum S; Remke J; Zimmer K; Bauters C; de Groote P; Boon RA; de Windt LJ; Preissl S; Hein L; Batkai S; Pinet F; Thum T
    J Am Coll Cardiol; 2016 Oct; 68(14):1557-71. PubMed ID: 27687198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.